This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
OncoVent Pancreatic Cancer Candidate
OncoVent Co., Ltd.
Drug Names(s): OncoVent immunotherapy
Description: OncoVent is focused on the development, manufacturing and commercialization of Cancer Immunotherapy Products within China with pancreatic cancer as its first target. BioMedTracker will update this profile when more information becomes available.
OncoVent Pancreatic Cancer Candidate News
Pink Sheet Nutraceutical R&D In Brief
Additional information available to subscribers only: